Levemir (insulin detemir) is used to treat diabetes mellitus, including diabetes type 1 and diabetes type 2. There are currently no generic options for any insulin brand. It is covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost.The lowest GoodRx price for the most common version of Levemir is around $446.08, 17% off the average retail price of $540.95. Compare insulins.

Insulin Detemir Latest News

GoodRx has completed the largest library of brand-drug savings programs on the internet, featuring over 800 manufacturer discount programs and 1,300 patient assistance programs for more than 1,600 drugs.*

This database, which took more than five years of research and development, includes discounts made available by dozens of drug manufacturers, and offers savings for both uninsured and insured patients.See More

Back in 2016, manufacturers Eli Lilly and Boehringer Ingelheim launched a new long-acting insulin, Basaglar, and marketed it as the cheaper alternative to blockbuster insulin Lantus. Basaglar contains the same kind of insulin as Lantus (insulin glargine), and while it is cheaper—Basaglar costs about 15% less than Lantus—it is still expensive, with a cash price of around $450 for a 30-day supply.

Despite outrage over the high cost of insulin, prices for popular insulin treatments have continued to climb in 2018, according to a GoodRx analysis of drug prices.

Though prices are not climbing as quickly as they did between 2002 and 2013—when the average cost of insulin therapy tripled—the average price of insulin has increased by 64% since January 2014. The most recent price increases are on insulins made by Sanofi-Aventis and Novo Nordisk, which raised prices by as much as 3% in May and July of this year, respectively. See More

Comparing long-acting insulins? Tresiba may come out ahead. With the exception of NPH insulins like Humulin N and Novolin N (which are now considered to be intermediate acting), they are all going to cost you. So, if you are already paying big bucks for your long-acting insulin, here are some things to think about.

What is a long-acting or basal insulin?

This is your baseline insulin, the insulin that is secreted to control your sugars when you are not eating (also known as the fasting state). See More

Cutting down or rationing insulin has dire consequences for all type 1 as well as type 2 diabetics dependent on insulin. Working in a busy practice alongside an endocrinologist with predominantly type 1 diabetic patients, I’ve seen the team behind our doctors working hard to keep insulin affordable for patients. Here is what I’ve learned from the best.

Long-acting insulins are only administered once or twice daily, and include drugs like Lantus, Toujeo, Basaglar, and Levemir. As of March 27th, we have a new one to add to the long-acting insulin family – Toujeo Max SoloStar.

What is Toujeo Max SoloStar indicated for?

Toujeo Max SoloStar is indicated to improve blood sugar control in adults with diabetes. It will be available in a 3 ml disposable prefilled SoloStar pen in the strength of 300 units/ml. See More

One of the only ways to treat diabetes type 1 and 2 are through insulin injections, like Lantus (insulin glargine), that help to control blood sugar. Unfortunately, doctors consistently report low levels of adherence to insulins, Lantus included. The main reason? The cost.

Lantus is a prime example of an expensive insulin—averaging around $274 per month, it is unaffordable for many. But GoodRx is here to help.See More

The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.

In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.